TELOMIR PHARMACEUTICALS, INC.

Press Releases Telomir Pharmaceuticals, Inc.

Equities

TELO

US87975F1049

Market Closed - Nasdaq Other stock markets 21:00:00 07/06/2024 BST			5-day change	1st Jan Change
5.63 ^USD	+8.69%		-6.94%	0.00%

05-30	Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1	CI
05-13	Telomir Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1	05-30	AQ
Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support	05-16	AQ
Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1	05-07	AQ
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.	04-16	AQ
Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024	04-02	AQ
Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines	03-26	AQ
Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th	03-22	AQ
Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal Science	03-14	AQ
Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference	03-07	AQ
Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal	03-05	AQ
Telomir Pharmaceuticals Announces Closing of Initial Public Offering	02-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW